Tingxi Tang

Tingxi Tang

Auto-generated profile, based on publicly available information

Tingxi Tang

Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China. 1

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2024 in Clinical Cancer Research
Verified
Journal Article
Open access
TTTingxi Tang
Tingxi Tang
ZZZhenhua Zhou
Zhenhua Zhou
MCMin Chen
Min Chen
NLNan Li
Nan Li
JSJianda Sun
Jianda Sun
JGJian Guan
Jian Guan
Purpose: The efficacy of induction chemotherapy (IC) as a primary treatment for advanced nasopharyngeal carcinoma (NPC) remains a topic of debate, with a lack of dependable biomarkers for predicting its efficacy. This study seeks to establish a predictive classifier using plasma metabolomics profiles. Patients and Methods: A total of 166 NPC patients enrolled in the clinical trial NCT05682703 who were undergoing IC were included in the study. Plasma lipoprotein profiles were obtained using 1H-nuclear magnetic resonance before and after IC treatment. An artificial intelligence-assisted radiomics method was developed to effectively evaluate its efficacy. Metabolic biomarkers were identified through a machine learning approach based on a discovery cohort and subsequently validated in a validation cohort that mimicked the most unfavorable real-world scenario. Results: Our research findings indicate that the effectiveness of IC varies among individual patients, with a correlation observed between efficacy and changes in metabolite profiles. Using machine learning techniques, it was determined that the extreme gradient boosting model exhibited notable efficacy, attaining an area under the curve (AUC) value of 0.792 (95% CI, 0.668–0.913). In the validation cohort, the model exhibited strong stability and generalizability, with an AUC of 0.786 (95% CI, 0.533–0.922). Conclusions: In this study, we found that dysregulation of plasma lipoprotein may result in resistance to IC in NPC patients. The prediction model constructed based on the plasma metabolites’ profile has good predictive capabilities and potential for real-world generalization. This discovery has implications for the development of treatment strategies and may offer insight into potential targets for enhancing the effectiveness of IC.


15 July 2024
Verified
Other
Open access
TTTingxi Tang
Tingxi Tang
ZZZhenhua Zhou
Zhenhua Zhou
MCMin Chen
Min Chen
NLNan Li
Nan Li
JSJianda Sun
Jianda Sun
JGJian Guan
Jian Guan
Purpose:The efficacy of induction chemotherapy (IC) as a primary treatment for advanced nasopharyngeal carcinoma (NPC) remains a topic of debate, with a lack of dependable biomarkers for predicting its efficacy. This study seeks to establish a predictive classifier using plasma metabolomics profiles.Patients and Methods:A total of 166 NPC patients enrolled in the clinical trial NCT05682703 who were undergoing IC were included in the study. Plasma lipoprotein profiles were obtained using 1H-nuclear magnetic resonance before and after IC treatment. An artificial intelligence-assisted radiomics method was developed to effectively evaluate its efficacy. Metabolic biomarkers were identified through a machine learning approach based on a discovery cohort and subsequently validated in a validation cohort that mimicked the most unfavorable real-world scenario.Results:Our research findings indicate that the effectiveness of IC varies among individual patients, with a correlation observed between efficacy and changes in metabolite profiles. Using machine learning techniques, it was determined that the extreme gradient boosting model exhibited notable efficacy, attaining an area under the curve (AUC) value of 0.792 (95% CI, 0.668–0.913). In the validation cohort, the model exhibited strong stability and generalizability, with an AUC of 0.786 (95% CI, 0.533–0.922).Conclusions:In this study, we found that dysregulation of plasma lipoprotein may result in resistance to IC in NPC patients. The prediction model constructed based on the plasma metabolites’ profile has good predictive capabilities and potential for real-world generalization. This discovery has implications for the development of treatment strategies and may offer insight into potential targets for enhancing the effectiveness of IC.

15 July 2024
Verified
Other
Open access
PDF file
TTTingxi Tang
Tingxi Tang
ZZZhenhua Zhou
Zhenhua Zhou
MCMin Chen
Min Chen
NLNan Li
Nan Li
JSJianda Sun
Jianda Sun
JGJian Guan
Jian Guan
Supplementary Figure S2. Comparison of different lipoprotein profiles between patients with different IC efficacy

15 July 2024
Verified
Other
Open access
TTTingxi Tang
Tingxi Tang
ZZZhenhua Zhou
Zhenhua Zhou
MCMin Chen
Min Chen
NLNan Li
Nan Li
JSJianda Sun
Jianda Sun
JGJian Guan
Jian Guan
Supplementary Table S4. Baseline characteristics of patients in discovery cohort